with market cap> $500M on 10/17/2012 identified Exelixis (NASDAQ: EXEL ), Momenta (NASDAQ: MNTA ), Pozen (NASDAQ: POZN ), and Questcor (NASDAQ: QCOR ). An equally weighted portfolio containing these two losers (-62% and -22
Technologies (NYSE: ESL ), Johnson Controls (NYSE: JCI ), Nexstar Broadcasting Group (NASDAQ: NXST ), Pozen (NASDAQ: POZN ), China Lodging Group (NASDAQ: HTHT ), CVS Caremark (NYSE: CVS ), Home Inns & Hotels Management Inc
qtr). GSK assigned the product development and commercialization agreement (PDC Agreement) between GSK and Pozen (NASDAQ: POZN ) to Pernix. Updated 2014 guidance : revenue: $110M - 120M; non-GAAP EBITDA: $22M - 24M. 2015 guidance
Pozen , Inc. (NASDAQ: POZN ) Q2 2014 Earnings Conference Call August 7, 2014 ..... Operator Greetings and welcome to the POZEN Incorporated second quarter 2014 earnings ..... you, and good morning. On behalf of POZEN , I would like to welcome everyone to
Pozen ( POZN +0.5% ) Q2 results : Revenues: $7.4M (+335.3%); Operating Expenses: $4.4M (-21.7%); Net Income: $3.0M (+175.2%); EPS: $0.09 (+169.2%); Quick Assets: $31.8M (-3.0%). No guidance given. Post your comment!
The following audio is from a conference call that will begin on August 07, 2014 at 11:00 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion. Listen now Complete Story »
resembling a consensus on best practices for money funds. For example, earlier this week two former fund executives, Robert Pozen and Terry Hamacher, penned an Opinion article in The Wall Street Journal that stated support for the first of the SEC's two